Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer
Authors
Keywords
-
Journal
GLYCOBIOLOGY
Volume 26, Issue 2, Pages 155-165
Publisher
Oxford University Press (OUP)
Online
2015-10-08
DOI
10.1093/glycob/cwv088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
- (2015) Ling-Yen Chung et al. Oncotarget
- Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury
- (2014) Vladislav Volarevic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulation of Alternative Macrophage Activation by Galectin-3
- (2014) A. C. MacKinnon et al. JOURNAL OF IMMUNOLOGY
- A Methylation-Phosphorylation Switch Determines Sox2 Stability and Function in ESC Maintenance or Differentiation
- (2014) Lan Fang et al. MOLECULAR CELL
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
- (2014) Soufiane Boumahdi et al. NATURE
- Induction of Cancer Stem Cell Properties in Colon Cancer Cells by Defined Factors
- (2014) Nobu Oshima et al. PLoS One
- The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
- (2014) M. A. Lemmon et al. Cold Spring Harbor Perspectives in Biology
- Understanding and targeting cancer stem cells: therapeutic implications and challenges
- (2013) Ke Chen et al. ACTA PHARMACOLOGICA SINICA
- The PML isoform IV is a negative regulator of nuclear EGFR’s transcriptional activity in lung cancer
- (2013) Hong-Yi Kuo et al. CARCINOGENESIS
- SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells
- (2013) Adrian P. Rybak et al. CELLULAR SIGNALLING
- The multiple roles for Sox2 in stem cell maintenance and tumorigenesis
- (2013) Kuancan Liu et al. CELLULAR SIGNALLING
- Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma
- (2013) Lei Ma et al. FEBS Journal
- Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
- (2013) Peter G. Traber et al. PLoS One
- The Emerging Role of SOX2 in Cell Proliferation and Survival and Its Crosstalk with Oncogenic Signaling in Lung Cancer
- (2013) Yu-Ting Chou et al. STEM CELLS
- Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
- (2012) M. C. Clark et al. BLOOD
- Galectin-3 Regulates Intracellular Trafficking of EGFR through Alix and Promotes Keratinocyte Migration
- (2012) Wei Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
- (2012) Sandeep Singh et al. Molecular Cancer
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- EGFR Kinase Promotes Acquisition of Stem Cell-Like Properties: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma Stem Cells
- (2012) Eric L. Abhold et al. PLoS One
- Proteomic Comparison of MCF-7 Tumoursphere and Monolayer Cultures
- (2012) Brian J. Morrison et al. PLoS One
- The Carbohydrate-Binding Site in Galectin-3 Is Preorganized To Recognize a Sugarlike Framework of Oxygens: Ultra-High-Resolution Structures and Water Dynamics
- (2011) Kadhirvel Saraboji et al. BIOCHEMISTRY
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells
- (2011) J Merlin et al. ONCOGENE
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF
- (2010) Y.-T. Chou et al. CANCER RESEARCH
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation
- (2010) S.-H. Chiou et al. CANCER RESEARCH
- Mutational Tuning of Galectin-3 Specificity and Biological Function
- (2010) Emma Salomonsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence That SOX2 Overexpression Is Oncogenic in the Lung
- (2010) Yun Lu et al. PLoS One
- Galectin-3: a novel mediator of heart failure development and progression
- (2009) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition of N-Linked Glycosylation Disrupts Receptor Tyrosine Kinase Signaling in Tumor Cells
- (2008) J. N. Contessa et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started